About us
About us
Management
Board of Directors
Scientific Advisory Board
T1D Scientific Advisory Board
Science
Nimvec™ Platform
Gene therapy
Publications
Advisory Boards
Pipeline
Pipeline
Type 1 Diabetes
Obesity / T2DM
Multiple Sclerosis
Hemophilia B
Hemophilia A
Age-related Macular Degeneration
Partners
News & Events
Press releases
In the news
Meet us
Working here
Working here
Open positions
Contact
Science
Publications
Poster: Tolerization Therapy for Treating Type 1 Diabetes Mellitus
ADA scientific sessions 21-24 June 2024, Orlando, Florida
Tolerization for Treating Type 1 Diabetes Mellitus
Diabetes Technology & Therapeutics Vol. 26, No. S2
Tolerization for treating neurodegenerative and psychiatric diseases
Journal of Affective Disorders Reports 12 (2023) 100517
Viral gene delivery vectors: the next generation medicines for immune-related diseases
Hum Vaccin Immunother . 2021 Jan 2;17(1):14-21. doi:10.1080/21645515.2020.1757989
Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy
Front. Psychiatry (2017) 8: 46. doi: 10.3389/fpsyt.2017.00046.
Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies
Mol. Ther. Methods Clin. Dev. (2017) 6: 124-134. doi: 10.1016/j.omtm.2017.06.007.
Recombinase Mediates the Removal of Bacterial Backbone to Efficiently Generate rSV40
Mol. Ther. Methods Clin. Dev. (2018) 9: 225-233. doi: 10.1016/j.omtm.2018.02.010
How Simian Virus 40 Hijacks the Intracellular Protein Trafficking Pathway to Its Own Benefit … and Ours
Front. Immunol (2018) 9: 1160. doi: 10.3389/fimmu.2018.01160.
LOAD MORE
TERMS & CONDITIONS
PRIVACY POLICY / COOKIES
© 2024 AMARNA THERAPEUTICS
